Glucocorticoids inhibit activation-dependent expression of costimulatory molecule B7-1 in human monocytes

Transplantation

Volumn 66, Issue 3, 1998, Pages 370-375

  Girndt, Matthias ^b   Sester, Urban ^b   Kaul, Harald ^b   Hünger, Frank ^b   Köhler, Hans ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; MIFEPRISTONE; PREDNISONE;

ANTIGEN PRESENTING CELL; ARTICLE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

EID: 0032529652     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808150-00015     Document Type: Article

References (24)

1. Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992; 71: 1065.
2. Janeway CAJ, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994; 76: 275.
3. Freeman GJ, Freedman AS, Segil JM, Lee G, Whitman F, Nadler LM. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol 1989; 143: 2714.
4. Freeman GJ, Gribben JG, Boussiotis VA, et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993; 262: 909.
5. Azuma M, Ito D, Yagita H, et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366: 76.
6. Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, Peach R. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1994; 1: 793.
7. Schmittel A, Scheibenbogen C, Keilholz U. Lipopolysaccharide effectively up-regulates B7-1 (CD80) expression and costimulatory function of human monocytes. Scand J Immunol 1995; 42: 701.
8. Hathcock KS, Laszlo G, Pucillo C, Linsley PS, Hodes RJ. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 1994; 180: 631.
9. Tobler A, Meier R, Seitz M, Dewald B, Baggiolini M, Fey MF. Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 1992; 79: 45.
10. Panarelli M, Holloway CD, Mulatero P, Fraser R, Kenyon CJ. Inhibition of lysozyme synthesis by dexamethasone in human mononuclear leukocytes: an index of glucocorticoid sensitivity. J Clin Endocrinol Metabol 1994; 78: 872.
11. Van de Stolpe A, Caldenhoven E, Raaijmakers JA, Van der Saag PT, Koenderman L. Glucocorticoid-mediated repression of intracellular adhesion molecule-1 expression in human monocytic and bronchial epithelial lines. Am J Respir Cell Mol Biol 1993; 8: 340.
12. Wahl LM, Katona IM, Wilder RL, et al. Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B- lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cytometric analysis. Cell Immunol 1984; 85: 373.
13. de Boer M, Parren P, Dove J, Ossendorp F, van der Horst G, Reeder J. Functional characterization of a novel anti-B7 monoclonal antibody. Eur J Immunol 1992; 22: 3071.
14. Larsen CP, Ritchie SC, Hendrix R, et al. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 1994; 152: 5208.
15. Freedman AS, Freeman GJ, Rhynhart K, Nadler LM. Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol 1991; 137: 429.
16. Nabavi N, Freeman GJ, Gault A, Godfrey D, Nadler LM, Glimcher LH. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 1992; 360: 266.
17. Watts TH, Alaverdi N, Wade WF, Linsley PS. Induction of costimulatory molecule B7 in M12 B lymphomas by cAMP or MHC-restricted T cell interaction. J Immunol 1993; 150: 2192.
18. Zhao JL, Freeman GJ, Gray GS, Nadler LM, Glimcher LH. A cell type-specific enhancer in the human B7.1 gene regulated by NF-κB. J Exp Med 1996; 183: 777.
19. Gajewski TF. B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro. J Immunol 1996; 156: 465.
20. Kuchroo VK, Das MP, Brown JA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80: 707.
21. Petro TM, Chen SS, Panther RB. Effect of CD80 and CD86 on T-cell cytokine production. Immunol Invest 1995; 24: 965.
22. Freeman GJ, Boussiotis VA, Anumanthan A, et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995; 2: 523.
23. Moser M, De Smedt T, Sornasse T, et al. Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur J Immunol 1995; 25: 2818.
24. Moguilewsky M, Philibert D. RU 38486: potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation. J Steroid Biochem 1984; 20: 271.